Grid Therapeutics' Series A Round

Grid Therapeutics raised a round of funding on September 14, 2017.

Grid Therapeutics is a biotechnology company developing a human derived targeted immunotherapy which leverages a novel approach of identifying specific tumor immunoglobulin G (IgG) antibodies from pat…

Articles about Grid Therapeutics' Series A Round: